Not finding it? Sign in to also search OpenAlex live.
-
Abstract 6970: Changes in Cardiovascular Prognostic Markers of Central and Visceral Adiposity in Older and Younger Adults Living with Obesity/Overweight with ≥1 Weight-Related Comorbidity in a Phase 2 Trial of Enicepatide, a GLP-1/GIP Agonist
Nikolaus Marx, Javed Butler, Helen Colhoun, Xuwei Hou, Julie Ishida, Macy Gipson, +2 more
0citations -
Weight loss and blood pressure lowering with GLP-1 receptor agonists and multi-hormone receptor modulators in overweight and obesity: a systematic review and meta-regression of phase 3 clinical trials
Massimo Nardone, Luxcia Kugathasan, Lauren Daunt, Ethan J. Parikh, Hao-Yuan River Zhang, Sachin Vidur Pasricha, +4 more
0citations -
Study protocol of a randomized, double-blind, placebo-controlled, multi-center trial to treat antipsychotic-induced weight gain: the Metformin-Lifestyle in antipsychotic users (MELIA) trial
Nini de Boer, Sinan Gülöksüz, Caroline G. C. M. van Baal, Leonie Willebrands, Jeroen Deenik, Christiaan H. Vinkers, +18 more
5citations -
Impact of exenatide on weight loss and eating behavior in adults with craniopharyngioma-related obesity: the CRANIOEXE randomized placebo-controlled trial2024 European Journal of Endocrinology article Medicine Pharmacology and Obesity Treatment Open access
Blandine Gatta‐Cherifi, Kamel Mohammedi, Tanguy Cariou, Christine Poitou, Philippe A. Touraine, Gérald Raverot, +11 more
27citations -
Weight Loss and Durability of Gastric Banding in Adolescents with Severe Obesity: 8-year Follow-up of a Randomized Controlled Trial2026 European Journal of Pediatric Surgery article Medicine Bariatric Surgery and Outcomes Open access
Fien de Boom, Ali Talib, Yvonne G. M. Roebroek, Givan Florian Paulus, Björn Winkens, Nicole D. Bouvy, +1 more
2citations